4-Phenyl-[1,2,3]thiadiazole-5-carboxylic acid ethyl ester, 95.0%, 1g

2-Aminopyrimidin-5-ol, 95.0%, 250mg

Fase de planificación PLPHi S100x/1,25 objetivo IOS de inmersión en aceite con corrección infinita. Distancia de trabajo 0,36 mm

1-Methylindole-5-carboxylic acid, 96.0%, 25g

2-Bromo-1-(4-chloro-3-methylphenyl)ethanone, 95.0%, 1g

1,3-Difluoro-4-iodo-2-methylbenzene, 97%, 250mg

N-(2-chlorophenyl)-2-piperazin-1-ylacetamide, 100mg

AMISELIMOD HYDROCHLORIDE, 95%, 5mg

METHYL 5-BROMO-1H-PYRAZOLO[3,4-B]PYRIDINE-3-CARBOXYLATE, 95%, 100mg

Phenazine-1-carboxamide, 95.0%, 250mg

(R)-3-Ethylmorpholine, 95.0%, 250mg

Ethyl 2-amino-thiazole-5-carboxylate, 97.0%, 100g

2-(Pyridin-2-yl)benzo[d]oxazole, 97.0%, 5g